MBIO - MUSTANG BIO, INC.
1.165
-0.015 -1.288%
Share volume: 67,170
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.18
-0.01
-0.01%
Summary score
23%
Profitability
8%
Dept financing
7%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.13%
Return on assets
-15.56%
Return on sales
23800%
Return on invested capital
-392.68%
Total debt ratio
20.06%
Debt ratio change over timeo
0%
Current Ratio
15.66%
Quick Ratio
0%
Cash Position Ratio
13.43%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-23.53%
Return on assets
-16.25%
Return on sales
0%
Return on invested capital
-509.17%
Total debt ratio
28.76%
Debt ratio change over timeo
0%
Current Ratio
7.88%
Quick Ratio
0%
Cash Position Ratio
7.7%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-20.55%
Return on assets
-14.58%
Return on sales
0%
Return on invested capital
348.07%
Total debt ratio
26.65%
Debt ratio change over time
0%
Current Ratio
5.85%
Quick Ratio
0%
Cash Position Ratio
5.79%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MBIO | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -22.13% | 17.45% | 4.69% | 19.89% |
| Return on assets | -15.56% | 3.37% | 3.35% | 11.41% |
| Return on sales | 23800% | 23.96% | 25.96% | 42.05% |
| Return on invested capital | -392.68% | 5.2% | 4.37% | -272.99% |
| Profitability | 25% | 54% | 34% | 50% |
| Total debt ratio | 20.06% | 77% | 57.66% | 53.92% |
| Debt ratio change over time | 0% | 0% | 10.55% | 0% |
| Dept financing | 7% | 25% | 44% | 18% |
| Current Ratio | 7.88% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 7.7% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 22% | 29% | 18% |
| Short-term ratios | MBIO | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -23.53% | 44.06% | 6.24% | 17.3% |
| Return on assets | -16.25% | 3.88% | 3.22% | 9.33% |
| Return on sales | 0% | 27.04% | 24.93% | 40.02% |
| Return on invested capital | -509.17% | 9.69% | 4.96% | -224.06% |
| Profitability | 0% | 77% | 41% | 60% |
| Total debt ratio | 28.76% | 91.8% | 61.39% | 55.88% |
| Debt ratio change over time | 0% | 0% | 12.93% | 0% |
| Dept financing | 8% | 25% | 42% | 15% |
| Current Ratio | 7.88% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 7.7% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 26% | 31% | 23% |
